Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2141077 | Lung Cancer | 2013 | 7 Pages |
Abstract
EGFR mutation is an independent predictive factor for both BM treatment response and survival after BM in patients with lung adenocarcinoma. Further prospective studies on incorporation of EGFR mutation status into therapeutic strategy and survival prediction system for lung adenocarcinoma with BM are warranted.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shih-Hsin Hsiao, Horng-Chyuan Lin, Yu-Ting Chou, Sey-En Lin, Chia-Chun Kuo, Ming-Chih Yu, Chi-Li Chung,